...
首页> 外文期刊>Electronic Journal of Biology >Successful In Vitro Maturation of Oocytes Collected from Whole Porcine Ovaries Vitrification
【24h】

Successful In Vitro Maturation of Oocytes Collected from Whole Porcine Ovaries Vitrification

机译:从整个猪卵巢玻璃化中收集的卵母细胞成功体外成熟

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Ovarian cryopreservation has become more and more important not only as a tool of genetic resource and biodiversity conservation but also as a bio-medical application. Objective: The aim of the present study is to survey on slow freezing and vitrification method towards a simple method to cryopreserve intact ovary which can be applied in the field condition. The result of method base on evaluation of viability and maturation potential of immature oocytes were collective from frozen–thawed ovaries. Materials and methods: The whole porcine ovarian were vitrified using same cryoprotective solution in three groups (V1, V2 and V3) which the treatment time in ES solution is 15, 30 and 45 min, respectively comparing to slow freezing program. After three weeks of storage, frozen samples were thawed and immature oocytes were collected for in vitro maturation. FDA staining of immature oocytes was used to con?ˉ????rmed the viability and morphology of intracellular structures. The oocytes matured were evaluated by extrusion of the first polar body. Results: The percentage of viability oocytes was the highest in group V2 (7.03%) compare with that in other group V1; control group and V3 group (6.47; 0.91 and 0.65%, respectively). The maturation rate did differ in two groups V1 (6.47%) and V2 (7.03%), but it was not in control and V3. Conclusion: whole ovarian vitrified is already a feasible technique, it is possible to collect viable immature oocytes that have the ability to mature in vitro.
机译:背景:卵巢冷冻保存不仅作为遗传资源和生物多样性保护的工具,而且作为生物医学应用,已经变得越来越重要。目的:本研究的目的是调查慢速冷冻和玻璃化方法,以寻求一种可以在野外条件下应用的冷冻保存完整卵巢的简单方法。该方法的结果基于未冷冻卵母细胞的存活力和未成熟卵母细胞成熟潜力的评估。材料和方法:使用相同的冷冻保护溶液将整个猪卵巢玻璃化,分为三组(V1,V2和V3),与慢速冷冻程序相比,在ES溶液中的处理时间分别为15分钟,30分钟和45分钟。储存三周后,将冷冻样品融化,并收集未成熟的卵母细胞进行体外成熟。 FDA未成熟卵母细胞染色被用于确认细胞内结构的活力和形态。通过挤压第一极体来评估成熟的卵母细胞。结果:与其他V1组相比,V2组的卵母细胞存活率最高(7.03%)。对照组和V3组(分别为6.47、0.91和0.65%)。两组V1(6.47%)和V2(7.03%)的成熟率确实有所不同,但对照组和V3却没有。结论:将整个卵巢玻璃化已经是可行的技术,有可能收集具有体外成熟能力的未成熟卵母细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号